Literature DB >> 7817807

Bone mass improves in alcoholics after 2 years of abstinence.

P Peris1, A Parés, N Guañabens, L Del Río, F Pons, M J Martínez de Osaba, A Monegal, J Caballería, J Rodés, J Muñoz-Gómez.   

Abstract

To evaluate the effect of abstinence on bone mass and bone mineral metabolism in chronic alcoholics, a 2 year longitudinal follow-up study was carried out in a group of 30 chronic alcoholic males who started a rehabilitation program. Lumbar and femoral bone mineral density (BMD) and serum levels of osteocalcin and 25-hydroxyvitamin D were measured at entry and after 1 and 2 years in all patients. Circulating cortisol and parathyroid hormone were measured in 14 and 6 patients, respectively, at entry and every year. Testosterone was measured in 18 patients at entry and after 1 year. At entry, lumbar BMD was significantly lower in alcoholics (1.06 +/- 0.03 g/cm2) than in age-matched healthy men (1.22 +/- 0.03 g/cm2; p < 0.001). Circulating osteocalcin and vitamin D levels were also significantly lower in alcoholics than in controls. Lumbar and femoral neck BMD increased in alcoholics after 2 years of abstinence (lumbar BMD, mean +/- SEM, 1.06 +/- 0.03 to 1.10 +/- 0.04 g/cm2, p < 0.05; femoral BMD, 0.82 +/- 0.02 to 0.84 +/- 0.02 g/cm2; p < 0.02). Moreover, lumbar BMD increased in alcoholics (2.9 +/- 1.4%) and decreased in controls (-1.1 +/- 0.2%; p < 0.02). Femoral BMD also increased in alcoholics (2.8 +/- 1.0%) but the expected mean decrease of -0.92% was found in healthy age-matched males. Baseline low osteocalcin levels (5.1 +/- 0.6 ng/ml) increased after 1 year (8.6 +/- 0.5 ng/ml, p < 0.001) and 2 years of abstinence (9.5 +/- 0.7 ng/ml, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817807     DOI: 10.1002/jbmr.5650091014

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  Low vitamin d status of patients in methadone maintenance treatment.

Authors:  Theresa W Kim; Daniel P Alford; Michael F Holick; Alan O Malabanan; Jeffrey H Samet
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

Review 2.  Alcoholism: a systemic proinflammatory condition.

Authors:  Emilio González-Reimers; Francisco Santolaria-Fernández; María Candelaria Martín-González; Camino María Fernández-Rodríguez; Geraldine Quintero-Platt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Corticosteroid-induced bone loss. Prevention and management.

Authors:  C Picado; M Luengo
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

Review 4.  Bone changes in alcoholic liver disease.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Eva Rodríguez-Rodríguez; Antonio Martínez-Riera; Julio Alvisa-Negrín; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2015-05-28

5.  Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery.

Authors:  M Kathleen Clark; Mary Fran R Sowers; Farideh Dekordi; Sara Nichols
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

Review 6.  Association between alcohol consumption and both osteoporotic fracture and bone density.

Authors:  Karina M Berg; Hillary V Kunins; Jeffrey L Jackson; Shadi Nahvi; Amina Chaudhry; Kenneth A Harris; Rubina Malik; Julia H Arnsten
Journal:  Am J Med       Date:  2008-05       Impact factor: 4.965

Review 7.  Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton.

Authors:  Gino W Gaddini; Russell T Turner; Kathleen A Grant; Urszula T Iwaniec
Journal:  Alcohol Clin Exp Res       Date:  2016-03-12       Impact factor: 3.455

Review 8.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

9.  Disulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agent.

Authors:  Hua Ying; An Qin; Tak S Cheng; Nathan J Pavlos; Sarah Rea; Kerong Dai; Ming H Zheng
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

Review 10.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.